학술논문

Sodium-glucose co-transporter 2 inhibitors reduce the abdominal visceral fat area and may influence the renal function in patients with type 2 diabetes
Document Type
Article
Source
In: Internal Medicine. (Internal Medicine, 2017, 56(6):597-604)
Subject
Language
English
ISSN
13497235
09182918